Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Moroder

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Biopolymers|March 3, 2004
Micellar environments induce structuring of the N-terminal tail of the prion proteinChristian Renner, Stella Fiori, Ferdinando Fiorino, et al.
Molecular Pharmacology|April 16, 2003
Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studiesCéline Galés, Marc Poirot, Julien Taillefer, et al.
Veterinary Microbiology|May 8, 2007
The configuration of the Cu(2+) binding region in full-length human prion protein compared with the isolated octapeptideAndreas Weiss, Pablo Del Pino, Uwe Bertsch, et al.
Chembiochem : a European Journal of Chemical Biology|September 16, 2004
Binding mode of TMC-95A analogues to eukaryotic 20S proteasomeMarkus Kaiser, Michael Groll, Carlo Siciliano, et al.
The Journal of Biological Chemistry|October 7, 2004
The glycoprotein NOWA and minicollagens are part of a disulfide-linked polymer that forms the cnidarian nematocyst wallSuat Ozbek, Elena Pokidysheva, Martine Schwager, et al.
Thrombosis and Haemostasis|December 21, 2005
Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activityIngo J Banke, Matthias J E Arlt, Markus M Mueller, et al.
The Journal of Biological Chemistry|November 29, 2001
The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation processChantal Escrieut, Véronique Gigoux, Elodie Archer, et al.
Pharmacology & Toxicology|April 12, 2003
Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonistsDaniel Fourmy, Chantal Escrieut, Elodie Archer, et al.
Biopolymers|January 22, 2013
Following the energy transfer in and out of a polyproline-peptideWolfgang J Schreier, Tobias Aumüller, Karin Haiser, et al.
The Journal of Biological Chemistry|May 5, 2004
The structure of the Cys-rich terminal domain of Hydra minicollagen, which is involved in disulfide networks of the nematocyst wallElena Pokidysheva, Alexander G Milbradt, Sebastian Meier, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Biopolymers|March 3, 2004
Micellar environments induce structuring of the N-terminal tail of the prion proteinChristian Renner, Stella Fiori, Ferdinando Fiorino, et al.
Molecular Pharmacology|April 16, 2003
Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studiesCéline Galés, Marc Poirot, Julien Taillefer, et al.
Veterinary Microbiology|May 8, 2007
The configuration of the Cu(2+) binding region in full-length human prion protein compared with the isolated octapeptideAndreas Weiss, Pablo Del Pino, Uwe Bertsch, et al.
Chembiochem : a European Journal of Chemical Biology|September 16, 2004
Binding mode of TMC-95A analogues to eukaryotic 20S proteasomeMarkus Kaiser, Michael Groll, Carlo Siciliano, et al.
The Journal of Biological Chemistry|October 7, 2004
The glycoprotein NOWA and minicollagens are part of a disulfide-linked polymer that forms the cnidarian nematocyst wallSuat Ozbek, Elena Pokidysheva, Martine Schwager, et al.
Thrombosis and Haemostasis|December 21, 2005
Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activityIngo J Banke, Matthias J E Arlt, Markus M Mueller, et al.
The Journal of Biological Chemistry|November 29, 2001
The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation processChantal Escrieut, Véronique Gigoux, Elodie Archer, et al.
Pharmacology & Toxicology|April 12, 2003
Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonistsDaniel Fourmy, Chantal Escrieut, Elodie Archer, et al.
Biopolymers|January 22, 2013
Following the energy transfer in and out of a polyproline-peptideWolfgang J Schreier, Tobias Aumüller, Karin Haiser, et al.
The Journal of Biological Chemistry|May 5, 2004
The structure of the Cys-rich terminal domain of Hydra minicollagen, which is involved in disulfide networks of the nematocyst wallElena Pokidysheva, Alexander G Milbradt, Sebastian Meier, et al.
Pageof 9